Skip to main content
Log in

Antineutrophil cytoplasmic antibody—A useful serological marker for vasculitis

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Systemic necrotizing vasculitides, including polyarteritis nodosa, Churg-Strauss syndrome, “overlap” systemic vasculitis, Wegener's granulomatosis, and idiopathic crescentic glomerulonephritis, are frequent clinical diagnostic problems. These diseases have diverse presentations and are often rapidly progressive, causing irreversible injury to the vessels of the kidneys and lungs before effective immunosuppressive therapy is instituted. Even in their less fulminant forms, they are a cause of significant morbidity and mortality. Antineutrophil cytoplasmic antibody, a recently identified autoantibody, has a high sensitivity and specificity for this spectrum of diseases. The clinical and pathological similarities, the high frequency of antineutrophil cytoplasmic antibody expression, and the similar good response to immunosuppressive therapy suggest that these diseases may be linked by a common pathophysiological mechanism. Evidence is growing that antineutrophil cytoplasmic antibody plays a central role in this mechanism. A revision in the classification scheme of vasculitides to recognize that the polyarteritis group (polyarteritis nodosa, Churg-Strauss syndrome, and “overlap” systemic vasculitis), Wegener's granulomatosis, and idiopathic crescentic glomerulonephritis are closely related diseases may be warranted. The clinical and pathological features of systemic necrotizing vasculitides and the current knowledge concerning antineutrophil cytoplasmic antibodies are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis: Clinical pathologic, immunologic and therapeutic considerations. Ann Intern Med 89:660–679, 1978

    Google Scholar 

  2. Kussmaul A, Maier R: Ueber eine bisher beschriebene eigentumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid for schreitender allgemeiner Muskellahmung einhergeht. Dtsch Arch Klin Med 1:484–518, 1866

    Google Scholar 

  3. Arkin A: A clinical and pathological study of periarteritis nodosa. A report of five cases, one histologically healed. Am J Pathol 6:401–426, 1930

    Google Scholar 

  4. Spiegel R: Clinical aspects of periarteritis nodosa. Arch Intern Med 68:993–1040, 1931

    Google Scholar 

  5. Davon J, Ball J, Platt R: The kidney in periarteritis nodosa. Q J Med 17:175–202, 1948

    Google Scholar 

  6. Savage COS, Winearls CG, Evan DJ, Rees AJ, Lockwood CM: Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56:467–483, 1985

    Google Scholar 

  7. Rose GA, Spencer H: Polyarteritis nodosa. Q J Med 26:43–81, 1957

    Google Scholar 

  8. Wainwright J, Davson J: The renal appearances in the microscopic form of periarteritis nodosa. J Pathol Bact 62:189–196, 1950

    Google Scholar 

  9. Rackemann FM, Greene CC: Periarteritis nodosa and asthma. Trans Assoc Am Phys 54:112–118, 1939

    Google Scholar 

  10. Nylson KS, Alexander HL: The relationship of periarteritis nodosa to bronchial asthma and other forms of human hypersensitiveness. J Lab Clin Med 30:195–203, 1945

    Google Scholar 

  11. Churg J, Strauss L: Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277–301, 1951

    Google Scholar 

  12. Cupps TR, Fauci AS: The vasculitides. Philadelphia, WB Saunders, 1981

    Google Scholar 

  13. Sergeant JS, Lockshin MD, Christin CL, Goeke DJ: Vasculitis with hepatitis B antigenemia: Long-term observations in nine patients. Medicine 55:1–18, 1976

    Google Scholar 

  14. Drüeke T, Barbanel C, Jungers P, Didgeon M, Poisson M, Brivet F: Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis. Am J Med 68:86–90, 1980

    Google Scholar 

  15. Paronetto F, Deppisch L, Tuchman LR: Lupus erythematosus with fatal hemorrhage into the liver and lesion resembling those of periarteritis nodosa and malignant hypertension. Immunocytochemical observations. Am J Med 36:948–955, 1964

    Google Scholar 

  16. Schmid FR, Cooper NS, Ziff M, McEwen: Arteritis in rheumatoid arthritis. Am J Med 30:56–83, 1961

    Google Scholar 

  17. Ronco P, Verroust P, Mifnon F, Kourilsky O, Vanhille P, Meyrier A, Merz JP, Morel-Maroger L: Immunopathological studies of polyarteritis nodosa and Wegener's granulomatosis: A report of 43 patients with 51 renal biopsies. Q J Med 52:212–223, 1983

    Google Scholar 

  18. Klinger H: Grenzformen der periarteritis nodosa. Frankfurt Z Pathol 42:455–480, 1931

    Google Scholar 

  19. Wegener F: Über generalisierk, septische Gefässerkrankungen. Verh Dtsch Ges Pathol 29:202–210, 1936

    Google Scholar 

  20. Wegener F: Über eine eigenartige rhinogene Granulomatose mit boson-derer Beterligung der Arterien systems und der Nieren. Beitr Pathol 102:36–68, 1939

    Google Scholar 

  21. Godman GC, Churg J: Wegener's granulomatosis: Pathology and review of the literature. Arch Pathol 58:533–553, 1954

    Google Scholar 

  22. Carrington CB, Liebow AA: Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 41:497–527, 1966

    Google Scholar 

  23. Shillitoe EJ, Lehner T, Lessof MH, Harrison DFN: Immunological features of Wegener's granulomatosis. Lancet 1:281–284, 1974

    Google Scholar 

  24. Israel HL, Patchefsky AS, Saldana MJ: Wegener's granulomatosis, lymphomatoid granulomatosis and benign lymphocytic angiitis and granulomatosis of the lung: Recognition and treatment. Ann Intern Med 87:691–699, 1977

    Google Scholar 

  25. Fauci AS, Wolff SM: Wegener's granulomatosis: Studies in eighteen patients and a review of the literature. Medicine 52:535–561, 1973

    Google Scholar 

  26. Pinching AJ, Rees AJ, Pussell BA, Lockwood CM, Mitchison RS, Peters DK: Relapses in Wegener's granulomatosis: The role of infection. Br Med J 281:836–838, 1980

    Google Scholar 

  27. DeRemee RA: The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: Illusion or vision? Arth Rheum 3:1068–1072, 1988

    Google Scholar 

  28. Cupps TR, Fauci AS: The vasculitides. Philadelphia, WB Saunders, 1981

    Google Scholar 

  29. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H: A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276, 1974

    Google Scholar 

  30. Tanaka N, Sekimoto K, Naoe S: Kawasaki disease: Relationship with infantile periarteritis nodosa. Arch Pathol Lab Med 100:81–86, 1976

    Google Scholar 

  31. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms and therapy. Am J Kid Dis 11:449–464, 1988

    Google Scholar 

  32. Nada AK, Torres VE, Ryu JK, Lie JT, Holley KE: Pulmonary fibrosis as an unusual manifestation of a pulmonary-renal vasculitis in elderly patients. Mayo Clin Proc 65:847–856, 1990

    Google Scholar 

  33. Cupps TR, Fauci AS: The Vasculitides. Philadelphia, WB Saunders, 1981, Chap 6

    Google Scholar 

  34. Davies D, Moran ME, Niall JF, Ryan GB: Segmental glomerulonephritis with anti-neutrophil antibody: Possible arbovirus aetiology. Br J Med 285:606, 1982

    Google Scholar 

  35. Hall JB, Wadham B, Wood CJ, Ashton V, Adam WR: Vasculitis and glomerulonephritis: A subgroup with antineutrophil cytoplasmic antibody. Aust NZ J Med 14:277–278, 1984

    Google Scholar 

  36. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425–429, 1985

    Google Scholar 

  37. Lüdemann G, Gross W: Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. Clin Exp Immunol 69:350–357, 1987

    Google Scholar 

  38. Parlevliet K, Henzen-Logmans S, Oe P, Bronsveld W, Balm AJM, Donker AJM: Antibodies to components of neutrophil cytoplasm: A new diagnostic tool in patients with Wegener's granulomatosis and systemic vasculitis. Q J Med 66:55–63, 1988

    Google Scholar 

  39. Lockwood CM, Bakes D, Jones S, Whitaker KB, Moss DW, Savage COS: Association of alkaline phosphatase with an autoantigen recognized by circulating antineutrophil antibodies in systemic vasculitis. Lancet 1:716–721, 1987

    Google Scholar 

  40. Venning M, Arfeen S, Bird A: Antibodies to neutrophils cytoplasmic antigen in systemic vasculitis. Lancet 2:850, 1987

    Google Scholar 

  41. Feehally J, Wheeler DC, Walls J, Jones S, Lockwood CM, Savage COS: A case of microscopic polyarteritis associated with antineutrophil cytoplasmic antibodies. Clin Nephrol 27:214–215, 1987

    Google Scholar 

  42. Wathen CW, Harrison DJ: Circulating antineutrophil antibodies in systemic vasculitis. Lancet 1:1037, 1987

    Google Scholar 

  43. Rasmussen N, Borregard N, Wiik A: Antineutrophil cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet 1:1488, 1987

    Google Scholar 

  44. Gross WL, Lüdemann J, Schroeder JM: Antineutrophil cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet 1:1488–1489, 1987

    Google Scholar 

  45. Goldschmeding R, Teteroo P, von dem Borne A: Antineutrophil cytoplasm antibodies in Wegener's granulomatosis are not directed against alkaline phosphatase. Lancet 1:1489, 1987

    Google Scholar 

  46. Wiik A: Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 97 (Suppl 6):12–13, 1989

    Google Scholar 

  47. van der Woude FJ, Kallenberg CGM eds: Proceedings of the 2nd International Workshop on antineutrophil cytoplasmic antibodies (ANCA). Netherlands J Med 36:87–171, 1990

  48. Jennette JC, Falk RJ: Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651–1657, 1988

    Google Scholar 

  49. Lüdemann J, Utecht B, Gross WL: Antineutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357–362, 1990

    Google Scholar 

  50. Niles JL, McCluskey RT, Ahmad MF, Amin Arnaout M: Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74:1888–1893, 1989

    Google Scholar 

  51. Goldschmeding R, van der Schoot CE, ten Bokkel Hunink D, Hack CE, van den Ende ME, Kallenberg CGM, von dem Borne AEGKr: Wegener's granulomatosis autoantibodies identify a novel diisopropyl fluorophosphate-binding protein in the lysosomes of normal human neutrophils. J Clin Invest 84:1577–1587, 1989

    Google Scholar 

  52. Jennette FC, Hoidal JH, Falk RJ: Specificity of antineutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75:2263–2264, 1990

    Google Scholar 

  53. Kao RC, Wehner NG, Skubitz KM, Gray BH, Hoidal JR: Proteinase 3: A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest 82:1963–1973, 1988

    Google Scholar 

  54. Jennette JC, Wilkman AS, Falk RJ: Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135:921–930, 1989

    Google Scholar 

  55. Charles LA, Falk RJ, Jennette JC: Reactivity of antineutrophil cytoplasmic autoantibodies with HL-60 cells. Clin Immunol Immunopathol 53:243–253, 1989

    Google Scholar 

  56. Goldschmeding R, Cohen Tervaert JW, van der Schoot CE, Kallenberg CGM, von dem Borne AEGKr: ANCA, anti-myeloperoxidase and anti-elastase: Three members of a novel class of autoantibodies against myeloid lysosomal enzymes. Acta Pathol Microbiol Immunol Scand 97 (Suppl 6): 48–49, 1989

    Google Scholar 

  57. Jennette JC, Falk RJ: Antineutrophil cytoplasmic autoantibodies and associated diseases: A review. Am J Kid Dis XV:517–529, 1990

    Google Scholar 

  58. Cohen Tervaert JW, Goldschmeding R, Elema JD, Limburg PC, van der Giessen M, Huitema MG, Koolen MI, Hené RJ, The TH, van der Hem GK, von dem Borne AEGKr, Kallenberg CGM: Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arth Rheum 33:1264–1272, 1990

    Google Scholar 

  59. Saxon A, Shanahan F, Landers C, Ganz T, Targan S: A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 86:202–210, 1990

    Google Scholar 

  60. Snook JA, Chapman RW, Fleming K, Jewell DP: Antineutrophil nuclear antibody in ulcerative colitis, Crohn's disease and primary sclerosing cholangiitis. Clin Exp Immunol 76:30–33, 1989

    Google Scholar 

  61. Nielsen H, Wiik A, Elmgreen J: Granulocyte specific antinuclear antibodies in ulcerative colitis. Acta Path Microbiol Immunol Scand Section C 91:23–26, 1983

    Google Scholar 

  62. Nässberger L, Sjöholm AG, Bygren P, Thyse UH, Højer-Madsen M, Rasmussen N: Circulating anti-neutrophil cytoplasm antibodies in patients with rapidly progressive glomerulonephritis and extra capillary proliferation. J Intern Med 225:191–196, 1989

    Google Scholar 

  63. Savage COS, Winearls CG, Jones S, Marshall PD, Lockwood CM: Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis. Lancet 1:1389–1393, 1987

    Google Scholar 

  64. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, DeRemes RA: Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener's granulomatosis. Mayo Clin Proc 64:28–36, 1989

    Google Scholar 

  65. Harrison DJ, Simpson R, Kharbanda RK, Abernethy VE, Nimmo G: Antibodies to neutrophil cytoplasmic antigens in Wegener's granulomatosis and other conditions. Thorax 44:373–377, 1989

    Google Scholar 

  66. Goeken JA, Seshi B: Antineutrophil cytoplasmic antibodies. Am Soc Clin Path Check Sample IP-90-1, 1990

  67. Nölle B, Specks U, Lüdemann J, Rohrbach M, DeRemee R, Gross W: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann Int Med 111:28–40, 1989

    Google Scholar 

  68. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH van der Hem GK, Kallenberg CGM: Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461–2465, 1989

    Google Scholar 

  69. Cohen Tervaert JW, Goldschmeding R, Hené RJ, Kallenberg CGM: Neutrophil cytoplasmic autoantibodies in Wegener's granulomatosis. Lancet 1:270, 1989

    Google Scholar 

  70. Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, von dem Borne AEGKr, Kallenberg CGM: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kid Int 37:799–806, 1990

    Google Scholar 

  71. Goeken JA, Bonsib S, Kemp JD: ANCA serology in rapidly progressive glomerulonephritis patients at a midwestern U.S. medical center. Am J Kidney Dis (in press)

  72. Savage COS, Tizard J, Jayne D, Lockwood CM, Dillon MJ: Anti-neutrophil cytoplasm antibodies in Kawasaki disease. Arch Dis Child 64:360–363, 1989

    Google Scholar 

  73. Goodpasture EW: The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158:863–870, 1919

    Google Scholar 

  74. Stanton MC, Tange JD: Goodpasture's syndrome (pulmonary hemorrhage associated with glomerulonephritis). Aust Ann Med 7:132–144, 1958

    Google Scholar 

  75. Lerner RA, Glassock KJ, Dixon FJ: The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med 126:989–1004, 1967

    Google Scholar 

  76. Holdsworth S, Boyce N, Thomson NM, Atkins RC: The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome). Q J Med 55:75–86, 1985

    Google Scholar 

  77. Bonsib SM, Walker WP: Pulmonary-renal syndrome: Clinical similarity amidst etiologic diversity. Mod Pathol 2:129–137, 1989

    Google Scholar 

  78. Case Records of the Massachusetts General Hospital. Case 46-1971. N Engl J Med 285:1187–1196, 1971

    Google Scholar 

  79. Wahls T, Bonsib SM, Schuster V: Co-existent Wegener's granulomatosis and anti-glomerular basement membrane disease. Hum Pathol 18:202–205, 1987

    Google Scholar 

  80. Lockwood CM, Jayne DRW, Marshall P, Jones SJ: A prospective study of the incidence of anti-GBM and anti-neutrophil cytoplasm antibodies in patients with rapidly progressive nephritis. Kidney Int 33:329, 1988

    Google Scholar 

  81. Pusey CD, Lockwood CM: Autoimmunity in rapidly progressive glomerulonephritis. Kidney Int 35:929–937, 1989

    Google Scholar 

  82. O'Donoghue DJ, Short CD, Brenchley PEC, Lawler W, Ballardie FW: Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol 32:251–255, 1989

    Google Scholar 

  83. Bonsib SM, Goeken JA, Kemp JD, Chandran P, Wilson L, Voigts A, Shadur C: Co-expression of anti-neutrophil cytoplasmic antibody (ANCA) in antiglomerular basement membrane mediated diseases. Am J Kid Dis (in press)

  84. Rasmussen N, Wiik A, Høier-Madsen M, Borregaard N, van der Woude FJ: Antineutrophil cytoplasm antibodies 1988. Lancet 1:706–707, 1988

    Google Scholar 

  85. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicalsin vitro. Proc Natl Acad Sci USA 87:4115–4119, 1990

    Google Scholar 

  86. Ewert B, Falk RJ, Jennette JC: Anti-neutrophil cytoplasmic antibodies stimulate neutrophils to injure endothelial monolayersin vitro. Am J Kidney Dis (in press)

  87. Lüdemann J, Csernok E, Ulmer M, Lemke H, Utecht B, Rautmann A, Gross WL: Anti-neutrophil cytoplasm anti-bodies in Wegener's granulomatosis: Immunodiagnostic value, monoclonal antibodies and characterization of the target antigen. Netherlands J Med 36:157–162, 1990

    Google Scholar 

  88. Dolman KM, Goldschmeding R, von dem Borne AEGKr, Hack CE: Alpha-1-anti-trypsin is the major inhibitor of the 29KD C-ANCA antigen. Am J Kid Dis (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goeken, J.A. Antineutrophil cytoplasmic antibody—A useful serological marker for vasculitis. J Clin Immunol 11, 161–174 (1991). https://doi.org/10.1007/BF00917422

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00917422

Key words

Navigation